Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
H610869-5mg | 5mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $572.90 | |
H610869-25mg | 25mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $2,000.90 |
Grade | Moligand™ |
---|---|
Action Type | INHIBITOR |
Mechanism of action | Inhibitor of NUAK family kinase 1;Inhibitor of NUAK family; SNF1-like kinase; 2 |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | N-(3-((5-iodo-2-((2-methoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)pyrimidin-4-yl)oxy)phenyl)propionamide |
---|---|
INCHI | InChI=1S/C25H29IN6O3/c1-4-23(33)28-17-6-5-7-19(14-17)35-24-20(26)16-27-25(30-24)29-21-9-8-18(15-22(21)34-3)32-12-10-31(2)11-13-32/h5-9,14-16H,4,10-13H2,1-3H3,(H,28,33)(H,27,29,30) |
InChi Key | KQMWYEJQANQTDM-UHFFFAOYSA-N |
Canonical SMILES | CCC(=O)Nc1cccc(c1)Oc1nc(ncc1I)Nc1ccc(cc1OC)N1CCN(CC1)C |
PubChem CID | 154699441 |
PubChem CID | 154699441 |
---|
Enter Lot Number to search for COA:
1. Juan WC, Hong W. (2016) Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer Therapy.. Genes (Basel), 7 (9): (589-97). [PMID:27589805] |
2. Yuan WC, Pepe-Mooney B, Galli GG, Dill MT, Huang HT, Hao M, Wang Y, Liang H, Calogero RA, Camargo FD. (2018) NUAK2 is a critical YAP target in liver cancer.. Nat Commun, 9 (1): (4834). [PMID:30446657] |
3. Dey A, Varelas X, Guan KL. (2020) Targeting the Hippo pathway in cancer, fibrosis, wound healing and regenerative medicine.. Nat Rev Drug Discov, 19 (7): (480-494). [PMID:32555376] |